Opinion

Video

Approach to Collaborative Care in Bladder Cancer

Author(s):

Axel Merseburger, MD, PhD,M. Carmen Mir, MD, PhD

The panel discusses the Large Urology Group Practice Association and provides insights on collaborative care approaches in bladder cancer.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
      Related Videos
      Suzanne B. Merrill, MD, FACS, answers a question during a Zoom video interview
      Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
      Urinary bladder | Image Credit: © magicmine - stock.adobe.com
      Expert describes implications of neoadjuvant durvalumab approval in MIBC
      Sima Porten, MD, on gene-environment interactions in bladder cancer development
      Sima Porten, MD, on gene-environment interactions in bladder cancer development
      3d rendered illustration - bladder cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
      How rBCG EAP could open up access for Anktiva in bladder cancer
      Betty Wang, MD, discusses studies from the 2025 EAU meeting
      Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
      Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
      Joshua J. Meeks, MD, PhD, discusses the impact of neoadjuvant durvalumab approval in MIBC
      Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
      Matthew Galsky, MD, reacts to NIAGARA results, durvalumab approval for MIBC
      Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
      Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link
      Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
      Eugene Cone, MD, outlines potential impact of Expanded Access Program for rBCG
      Human urinary bladder | Image Credit: © magicmine - stock.adobe.com
      How recombinant BCG could ease strain of supply issues
      Related Content
      Human Body Organs (Urinary Bladder) | Image Credit: @ magicmine - stock.adobe.com
      April 21st 2025

      Nadofaragene firadenovec elicits high CR rate in phase 3 trial in Japan

      Hannah Clarke
      Treatment with nadofaragene led to a complete response rate of 75% at 3 months.
      Dr. Schwen on focal therapies for prostate cancer
      January 11th 2024

      Dr. Schwen on focal therapies for prostate cancer

      Cleveland Clinic
      Zeyad Schwen, MD, a urologic oncologist at Cleveland Clinic, discusses how patient factors and cancer characteristics are key to deciding between focal therapies and whole gland treatment for prostate cancer.
      Urologists perform first remote robot–assisted HIFU for prostate cancer
      April 17th 2025

      Urologists perform first remote robot–assisted HIFU for prostate cancer

      Hannah Clarke
      “We are witnessing the dawn of teletreatment,” says Jihad Kaouk, MD, FACS.
      medical depiction of bladder cancer
      May 31st 2023

      Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

      Urology Times staff
      In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      April 17th 2025

      Exploring new avenues in non–muscle invasive bladder cancer treatment

      Urology Times staff
      Three recent expert-led Clinical Forums explored current challenges and advancements in the management of non–muscle invasive bladder cancer.
      FDA approval sought for Anktiva in papillary NMIBC
      April 15th 2025

      FDA approval sought for Anktiva in papillary NMIBC

      Hannah Clarke
      The sBLA is supported by data from cohort B of the pivotal QUILT-3.032 trial.
      © 2025 MJH Life Sciences

      All rights reserved.